Interleukin-2: Started two Phase III trials with partner Eli Lilly, enrolling 120 and 64 patients, respectively. Each trial will test two doses, 9 and 18 µg/kg

Seragen Inc. (SRGN), Hopkinton, Mass.
Product:

Read the full 60 word article

How to gain access

Continue reading with a
two-week free trial.